Document Detail

Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia.
MedLine Citation:
PMID:  18177447     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Postoperative adjuvant steroid treatment is reported to improve jaundice-free survival in biliary atresia (BA) patients and to reduce the need for early liver transplantation. However, evidence of all retrospective studies is very limited, although high-dose corticosteroids were favored. The aim of this dosage finding study was to test the most promising corticosteroid protocol in a smaller but representative series, in order to optimize the settings of upcoming prospective and long-term multicenter studies. METHODS: Our prospective single-center and open-labeled pilot study on high-dose steroids included 49 consecutive BA patients. Basic data of the study group were not different from 29 controls. In the study group, 20 consecutive patients were treated after the Kasai with methylprednisolone (10 mg/kg day 1 to 5 and 1 mg/kg day 6 to 28). RESULTS: Overall survival with native liver was 63% after 6 months and 31% after 2 yr, with no statistical difference between the study and control groups. After 2 yr, 27% of all patients were still jaundice-free. With regard to predictive parameters, we found, 6 months after the Kasai, bilirubin < 20 micromol/L as highly sensitive (97%) and specific (93%) for jaundice-free survival with native liver. CONCLUSIONS: In contrast to previous reports, this pilot study shows that high-dose steroid pulses after Kasai procedure are not effective in postoperative adjuvant therapy protocols and should be avoided in upcoming multicenter steroid studies. Therefore, we recommend extended and randomized multicenter studies to pre-evaluate the supposed effectiveness of alternative steroid protocols, by comparing, 6 months after the Kasai procedure, the number of patients with normal bilirubin.
Claus Petersen; Dörthe Harder; Michael Melter; Thomas Becker; Reinhard V Wasielewski; Johannes Leonhardt; Benno M Ure
Related Documents :
18346517 - Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis.
9550347 - Effect of topical cyclosporin a on thygeson's superficial punctate keratitis.
23974837 - Accelerated polyethylene wear and early failure of the uncemented reflection acetabular...
23129947 - Outcome of index finger pollicisation.
15186637 - Preoperative weight loss by intragastric balloon in super-obese patients treated with l...
12218617 - Effect of prostaglandin e1 on idiopathic sudden sensorineural hearing loss: a double-bl...
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2008-01-02
Journal Detail:
Title:  The American journal of gastroenterology     Volume:  103     ISSN:  0002-9270     ISO Abbreviation:  Am. J. Gastroenterol.     Publication Date:  2008 Mar 
Date Detail:
Created Date:  2008-03-17     Completed Date:  2008-06-06     Revised Date:  2009-04-06    
Medline Journal Info:
Nlm Unique ID:  0421030     Medline TA:  Am J Gastroenterol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  712-9     Citation Subset:  IM    
Department of Pedatric Surgery, Hannover Medical School, Hannover, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biliary Atresia / drug therapy,  mortality,  pathology,  surgery*
Chemotherapy, Adjuvant
Glucocorticoids / administration & dosage*
Liver / pathology
Liver Transplantation
Methylprednisolone / administration & dosage*
Postoperative Care
Survival Rate
Reg. No./Substance:
0/Glucocorticoids; 83-43-2/Methylprednisolone
Comment In:
J Pediatr Gastroenterol Nutr. 2009 Jan;48(1):115-6   [PMID:  19172135 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review.
Next Document:  Factors predictive of survival after percutaneous endoscopic gastrostomy in the elderly: is dementia...